bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and integrated products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. the crop protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. the crop nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. in addition, the company offers hb4, a drought tolerant seed technology program. it operates in argentina, austria, bolivia, brazil, lebanon, the united states, italy, paraguay, the united kingdom, south africa, france, canada, ukraine, uruguay, and internationally. the company is headquartered in rosario, argentina. bioceres crop solutions corp. is a subsidiary of bioceres llc.
Company profile
Ticker
BIOX, BIOX-AF
Exchange
Website
CEO
Federico Trucco
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
BIOX stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
28 Feb 24
6-K
Financial and Operating Results
9 Feb 24
6-K
Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report
24 Jan 24
6-K
Current report (foreign)
29 Nov 23
6-K/A
Current report (foreign) (amended)
29 Nov 23
20-F
2023 FY
Annual report (foreign)
14 Nov 23
6-K
FISCAL FIRST QUARTER 2024 Financial and Operating Results
13 Nov 23
NT 20-F
Notice of late annual filing (foreign)
30 Oct 23
6-K/A
Current report (foreign) (amended)
12 Oct 23
6-K
Current report (foreign)
11 Oct 23
Transcripts
BIOX
Earnings call transcript
2024 Q2
8 Feb 24
BIOX
Earnings call transcript
2023 Q4
11 Sep 23
BIOX
Earnings call transcript
2023 Q3
11 May 23
BIOX
Earnings call transcript
2023 Q2
9 Feb 23
BIOX
Earnings call transcript
2023 Q1
13 Nov 22
BIOX
Earnings call transcript
2022 Q4
8 Sep 22
BIOX
Earnings call transcript
2022 Q3
12 May 22
BIOX
Earnings call transcript
2022 Q2
10 Feb 22
BIOX
Earnings call transcript
2021 Q4
9 Sep 21
BIOX
Earnings call transcript
2021 Q3
14 May 21
Latest ownership filings
SC 13D/A
Bioceres Group PLC
25 Mar 24
SC 13G/A
Solel Partners LP
14 Feb 24
SC 13G
Solel Partners LP
14 Feb 23
SC 13G
ARDSLEY ADVISORY PARTNERS LP
25 Jan 23
SC 13G/A
DRACO Capital Investment Management Co Ltd
18 Nov 22
SC 13D/A
Bioceres S.A.
17 Nov 22
SC 13G/A
DRACO Capital Investment Management Co Ltd
4 Aug 22
SC 13D/A
Bioceres S.A.
25 Jul 22
SC 13G
Ospraie Ag Science LLC
15 Jul 22
SC 13D/A
Bioceres S.A.
5 Apr 22
Financial summary
Quarter (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
88.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 55 |
Opened positions | 9 |
Closed positions | 4 |
Increased positions | 13 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 101.16 bn |
Total shares | 55.62 mm |
Total puts | 32.30 k |
Total calls | 44.90 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
Bioceres | 31.56 mm | $440.90 mm |
5D+ Capital Investment Management | 8.16 mm | $115.37 mm |
Ospraie Ag Science | 6.23 mm | $58.85 mm |
Solel Partners | 4.58 mm | $51.70 bn |
Ardsley Advisory Partners | 1.85 mm | $20.92 bn |
Uniplan Investment Counsel | 470.96 k | $5.41 mm |
Arisaig Partners | 265.98 k | $3.00 bn |
Allianz Asset Management GmbH | 231.66 k | $2.62 bn |
Wellington Management | 229.81 k | $2.59 bn |
Long Focus Capital Management | 228.80 k | $2.58 bn |
News
Roth MKM Maintains Buy on Bioceres Crop Solutions, Raises Price Target to $21
9 Feb 24
Bioceres Crop Solutions Q2 2024 GAAP EPS $0.02 Misses $0.09 Estimate, Sales $140.30M Beat $116.99M Estimate
8 Feb 24
Earnings Scheduled For February 8, 2024
8 Feb 24
Earnings Preview For Bioceres Crop Solutions
7 Feb 24
Press releases
Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference
6 Mar 24
Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results
8 Feb 24
Bioceres Crop Solutions to Host Fiscal Second Quarter 2024 Financial Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time
25 Jan 24
Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report
23 Jan 24